FDA Clearance Tracker · P240003-S006
Minima Pro Stent System
Last checked: Nov 20, 2026Latest source record: Jul 9, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 9, 2026
Approved
Time to decision
198 days
Received Dec 23, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P240003-S006
- Device name
- Minima Pro Stent System
- Applicant
- Renata Medical, Inc.
- Applicant location
- Newport Beach, CA
- Received
- Dec 23, 2025
- Decided
- Jul 9, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P240003
Device type
- Device type
- Aortic stent (PNF)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for design modifications and a line extension to the Minima Stent System, including a stent design change from closed cell to hybrid open-cell, a new 10mm balloon size for expansion of the stent, delivery system design changes, and packaging design changes. The device, as modified, will be marketed under the trade name Minima Pro Stent System.
Source documents
Other decisions for Renata Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Minima Stent System and Minima Pro Stent SystemBreakthroughPMA
P240003 · Decided Aug 28, 2024 · 180 days after receipt
Device type: Aortic stent (PNF) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.